{"id":"NCT02517528","sponsor":"AbbVie","briefTitle":"ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis","officialTitle":"An Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT 450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Treatment-Naïve and Treatment-Experienced Asian Adults With GT1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-07-20","primaryCompletion":"2016-09-29","completion":"2017-03-16","firstPosted":"2015-08-07","resultsPosted":"2018-10-09","lastUpdate":"2018-10-09"},"enrollment":104,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Hepatitis C Virus (HCV)"],"interventions":[{"type":"DRUG","name":"ABT-450/r/ABT-267","otherNames":["ombitasvir/paritaprevir/ritonavir","ombitasvir also known as ABT-267","paritaprevir also known as ABT-450"]},{"type":"DRUG","name":"ABT-333","otherNames":["dasabuvir"]},{"type":"DRUG","name":"ribavirin","otherNames":[]}],"arms":[{"label":"ABT-450/r/ABT-267 + ABT-333 + Ribavirin","type":"EXPERIMENTAL"}],"summary":"This is a Phase 3, open-label, multicenter study evaluating the efficacy and safety of ABT-450/r/ ABT-267 and ABT-333 coadministered with RBV for 12 weeks in HCV genotype 1b, treatment naïve and Interferon (IFN) (alpha, beta or pegIFN) plus RBV treatment-experienced Asian adults with compensated cirrhosis.","primaryOutcome":{"measure":"Percentage of Participants Achieving Sustained Virologic Response 12 Weeks Post-Treatment (SVR12)","timeFrame":"12 weeks after last dose of study drug","effectByArm":[{"arm":"ABT-450/r/ABT-267 + ABT-333 + Ribavirin","deltaMin":100,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["29909549"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":104},"commonTop":["BLOOD BILIRUBIN INCREASED","PRURITUS","ANAEMIA","ASTHENIA","BILIRUBIN CONJUGATED INCREASED"]}}